Breast cancer survivor and advocate honoured
The Breast Cancer Aotearoa Coalition is thrilled its chairperson, Elisabeth Burgess (Libby), has been recognised in the 2011 New Year’s Honours.
Ms Burgess has become a Member of the New Zealand Order of Merit for her work with women, their families and communities affected by breast cancer.
The Coalition’s deputy chair, Dr Chris Walsh, says the award is well-deserved.
BCAC is delighted that Palmerston North oncologist, Dr Richard Isaacs, (pictured) has been acknowledged in the Queen’s Birthday honours as a Member of the New Zealand Order of Merit.
Dr Isaacs was instrumental in the battle to secure Government funding for a 12-month treatment programme of Herceptin for women with HER2 Positive breast cancer.
BCAC is mourning the passing of its former Treasurer, Sue Guthrie, who recently lost her battle with breast cancer.
Sue was only 47 when she died on November 11 2009, but she lived with courage, serenity and dignity to the end.
Hi my name is Jennifer Lucas. I would like to share my story with you in the hope that it inspires others to be strong, grow and remain positive through tough and trying times. I was 21 years old when diagnosed.
Hi. My name is Anne Hayden and I am a 60 year old woman with two adult children, and one stepdaughter and two grandsons living in the UK. I live in Devonport, Auckland, with my husband, David, boxer dog, and ginger cat.
…
FDA Press Release - Feb 11, 2011
The U.S. Food and Drug Administration has approved the Selenia Dimensions System, the first X-ray mammography device that provides three-dimensional (3-D) images of the breast for breast cancer screening and diagnosis.
11 August 2008
The Breast Cancer Aotearoa Coalition (BCAC) issued the following statement in response to issues raised in the current Herceptin debate:
Media Release from Dr Richard Isaacs, Medical Oncologist, Palmerston North and ANZ Breast Cancer Trials Group, Chair Breast Cancer Special Interest Group of the New Zealand Association of Cancer Specialists and Associate Professor Fran Boyle, Medical Oncologist, University of Sydney and ANZ Breast Cancer Trials Group.
12 August 2008
01 September 2008
The UICC (International Union Against Cancer) World Cancer Congress held last week in Geneva provided breast cancer advocate Dr Chris Walsh with a platform to present the plight of NZ women needing Herceptin to the international oncology community.
October 23, 2008
John Key’s announcement today that a National-led government will fund 12 months of Herceptin could bring immeasurable relief to women and their families affected by early stage HER2 positive breast cancer.
